North America Stem Cell Therapy Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 - COVID-19 Impact and Regional Analysis by Type (Adult Stem Cell Therapy, Embryonic Stem Cell Therapy, Induced Pluripotent Stem Cell Therapy, and Other Stem Cell Therapy), Treatment (Allogeneic and Autologous), Application (Musculoskeletal, Dermatology, Cardiology, Drug Discovery & Development, and Other Applications), and End User (Hospitals & Specialty Clinics and Academic & Research Institutes)

No. of Pages: 133    |    Report Code: BMIRE00028486    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
North America Stem Cell Therapy Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. North America Stem Cell Therapy Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. North America Stem Cell Therapy Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 Increasing Research Activities Related to Stem Cell Therapy for Effective Disease Management to Favor the Market Growth
  • 5.1.2 Increasing Funding in Cancer Management To Enhance the Stem Cell Research Will Drive the Market Growth
5.2 Market Opportunities
  • 5.2.1 Use of Induced Pluripotent Stem Cells in Regenerative Medicines to Provide Lucrative Market Opportunity
5.3 Future Trends
  • 5.3.1 Research activities and product innovations are likely to remain key trends in the market.
5.4 Impact of Drivers and Restraints

6. North America Stem Cell Therapy Market Regional Analysis

6.1 North America Stem Cell Therapy Market Overview
6.2 North America Stem Cell Therapy Market Revenue 2020-2028 (US$ Million)
6.3 North America Stem Cell Therapy Market Forecast Analysis

7. North America Stem Cell Therapy Market Analysis – by Type

7.1 Adult Stem Cell Therapy
  • 7.1.1 Overview
  • 7.1.2 Adult Stem Cell Therapy: North America Stem Cell Therapy Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Embryonic Stem Cell Therapy
  • 7.2.1 Overview
  • 7.2.2 Embryonic Stem Cell Therapy: North America Stem Cell Therapy Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Induced Pluripotent Stem Cell Therapy
  • 7.3.1 Overview
  • 7.3.2 Induced Pluripotent Stem Cell Therapy: North America Stem Cell Therapy Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Other Stem Cell Therapy
  • 7.4.1 Overview
  • 7.4.2 Other Stem Cell Therapy: North America Stem Cell Therapy Market – Revenue and Forecast to 2031 (US$ Million)

8. North America Stem Cell Therapy Market Analysis – by Treatment

8.1 Allogeneic
  • 8.1.1 Overview
  • 8.1.2 Allogeneic: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
8.2 Autologous
  • 8.2.1 Overview
  • 8.2.2 Autologous: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)

9. North America Stem Cell Therapy Market Analysis – by Application

9.1 Musculoskeletal
  • 9.1.1 Overview
  • 9.1.2 Autologous: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
9.2 Dermatology
  • 9.2.1 Overview
  • 9.2.2 Autologous: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
9.3 Cardiology
  • 9.3.1 Overview
  • 9.3.2 Autologous: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Drug Discovery & Development
  • 9.4.1 Overview
  • 9.4.2 Autologous: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Other Applications
  • 9.5.1 Overview
  • 9.5.2 Autologous: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)

10. North America Stem Cell Therapy Market – North America Analysis

10.1 North America
  • 10.1.1 North America Stem Cell Therapy Market Breakdown, by Key Country, 2023 and 2028 (%)
  • 10.1.1.1 North America Stem Cell Therapy Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 US: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.1.1 US: North America Stem Cell Therapy Market Breakdown, by Type
    • 10.1.1.1.2 US: North America Stem Cell Therapy Market Breakdown, by Treatment
    • 10.1.1.1.3 US: North America Stem Cell Therapy Market Breakdown, by Application
  • 10.1.1.2 Canada: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.2.1 Canada: North America Stem Cell Therapy Market Breakdown, by Type
    • 10.1.1.2.2 Canada: North America Stem Cell Therapy Market Breakdown, by Treatment
    • 10.1.1.2.3 Canada: North America Stem Cell Therapy Market Breakdown, by Application
  • 10.1.1.3 Mexico : North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.3.1 Mexico : North America Stem Cell Therapy Market Breakdown, by Type
    • 10.1.1.3.2 Mexico : North America Stem Cell Therapy Market Breakdown, by Treatment
    • 10.1.1.3.3 Mexico : North America Stem Cell Therapy Market Breakdown, by Application

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. North America Stem Cell Therapy Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 MEDIPOST
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 RichSource
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 BioTime, Inc.
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Mesoblast Limited
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 U.S. Stem Cell, Inc.
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 TiGenix NV
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 AlloSource
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 NuVasive Inc
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - N Market

  1. MEDIPOST
  2. RichSource
  3. BioTime, Inc.
  4. Mesoblast Limited
  5. U.S. Stem Cell, Inc.
  6. TiGenix NV
  7. AlloSource
  8. NuVasive Inc
north-america-stem-cell-therapy-market